Table 2. MicroRNAs associated with post-diagnostic survival and supporting independent studies.

MicroRNA	P-Value	Estimate	Hazard Ratio (95% C.I.1)	Relevant Literature References
hsa-miR-22*	<.0001	−1.4007	0.25 (0.14 to 0.44)	[24], [25], [30], [33], [36] O
hsa-miR-770-5p	<.0001	−1.2946	0.27 (0.16 to 0.47)	NA
hsa-miR-485-3p	<.0001	−0.8158	0.44 (0.30 to 0.66)	[28] O
hsa-miR-16	<.0001	0.7249	2.07 (1.53 to 2.79)	[24], [25], [27] O
hsa-miR-144	<.0001	0.2644	1.3 (1.14 to 1.49)	[24] O
ebv-miR-BHRF1-2*	0.0001	1.4787	4.39 (2.06 to 9.33)	NA2
hsa-miR-182*	0.0001	0.8547	2.35 (1.51 to 3.65)	[24], [25], [72], [73] O
hsa-miR-381	0.0001	0.6801	1.97 (1.40 to 2.79)	[31] O
hsa-miR-509-3-5p	0.0001	−0.3725	0.69 (0.57 to 0.83)	[74] O
hsa-miR-19a*	0.0002	0.5574	1.75 (1.31 to 2.33)	[24] O
hsa-miR-573	0.0007	0.6298	1.88 (1.31 to 2.70)	NA
hsa-miR-329	0.0031	−1.4082	0.25 (0.10 to 0.62)	[23] Z
hsa-miR-106b	0.0024	0.4525	1.57 (1.17 to 2.11)	[24], [25] O
hsa-miR-18b*	0.0042	0.6678	1.95 (1.24 to 3.08)	[24], [26] O
hsa-miR-521	0.0051	1.3416	I_II3 = 2.10 (0.89 to 4.97)	[30] O
			Rest4 = 0.55 (0.40 to 0.76)
hsa-miR-148a	0.0063	−0.2493	0.78 (0.65 to 0.93)	[28] O

¹C.I.: Confidence Interval;

²NA: No information found; ^OAssociated with Ovarian Cancer; ^ZAssociated with other cancer type;

³I_II: Grade I or II tumor;

⁴Rest: Any tumor grades other than I or II.